ACM
NVO

ADAR1 Capital Management’s Novo Nordisk NVO Stock Holding History

ADAR1 Capital Management’s Portfolio NVO Stock Details NVO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$1.29M Sell
27,000
-6,000
-18% -$258K 0.06% 157
2026
Q1 		$1.21M Buy
+33,000
New +$1.56M 0.07% 143
2024
Q3 		– Sell
-200
Closed -$26.7K – 321
2024
Q2 		$28.5K Buy
200
+100
+100% +$13.3K 0.01% 207
2024
Q1 		$12.8K Sell
100
-6,250
-98% -$744K ﹤0.01% 224
2023
Q4 		$657K Buy
+6,350
New +$628K 0.23% 54

Other funds holding NVO

Dodge & Cox
Dodge & Cox San Francisco, California $191B AUM 17.5% 1-Year Est. Return
Loomis, Sayles & Company
Loomis, Sayles & Company Boston, Massachusetts $79.8B AUM 16.05% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $462B AUM 39.16% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return
Capital International Investors
Capital International Investors Los Angeles, California $484B AUM 34.9% 1-Year Est. Return
F
Folketrygdfondet Oslo Norway, Norway $4.64B AUM 35.47% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return
Fisher Asset Management
Fisher Asset Management Camas, Washington $336B AUM 34.66% 1-Year Est. Return

ADAR1 Capital Management's NVO Position: Q2 2026 in Review

ADAR1 Capital Management reduced its Novo Nordisk (NVO) stake by 18% in Q2 2026, selling an estimated $258K and leaving 27,000 shares worth $1.29M. The position accounts for 0.06% of the portfolio, ranked #157.

ADAR1 Capital Management first reported a position in NVO in Q4 2023 and has held it in 5 quarters since. 1,350 funds tracked by Wall St. Rank hold NVO as of Q2 2026.

  • ADAR1 Capital Management held 27,000 shares of Novo Nordisk worth $1.29M as of Q2 2026.
  • ADAR1 Capital Management sold 6,000 Novo Nordisk shares in Q2 2026, an estimated $258K.
  • Novo Nordisk made up 0.06% of ADAR1 Capital Management's portfolio in Q2 2026, its #157 holding.
  • ADAR1 Capital Management first reported a position in Novo Nordisk in Q4 2023 and has held it in 5 quarters since.
  • 1,350 funds tracked by Wall St. Rank held Novo Nordisk as of Q2 2026.

Based on ADAR1 Capital Management's 13F filing for Q2 2026, filed 14 Aug 2026.